Solid Biosciences (SLDB) Receivables - Other (2020 - 2022)

Solid Biosciences has reported Receivables - Other for 3 years, with the latest figure at $14000.0 in Q1 2022.

• Quarterly Receivables - Other fell 95.0% year-over-year to $14000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $14000.0 (down 95.0% YoY) and the FY2021 annual result came in at $110000.0, changed N/A from the prior year.
• Receivables - Other eased to $14000.0 in Q1 2022 per SLDB's latest filing, from $110000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $594000.0 in Q3 2021 and troughed at $14000.0 in Q1 2022.
• A 3-year average of $261666.7 and a median of $283000.0 in 2020 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2021 and 2022: Receivables - Other changed 0.0% in 2021, then sank 95.0% in 2022.
• Over 3 years, Receivables - Other stood at $286000.0 in 2020, then slumped by 61.54% to $110000.0 in 2021, then sank by 87.27% to $14000.0 in 2022.
• According to Business Quant data, Receivables - Other over the past three periods registered $14000.0, $110000.0, and $594000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.